RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Coloplast A/S Stock

Coloplast A/S Equity 2024

Coloplast A/S Equity

17.94 B DKK

Ticker

COLO B.CO

ISIN

DK0060448595

WKN

A1KAGC

In 2024, Coloplast A/S's equity was 17.94 B DKK, a 116.38% increase from the 8.29 B DKK equity in the previous year.

Coloplast A/S Aktienanalyse

What does Coloplast A/S do?

Coloplast A/S is a Danish company that has been manufacturing products for people with stoma, incontinence, and wound care needs since 1957. The company's headquarters is located in Humlebæk, Denmark, and it employs over 12,000 employees worldwide. Translated: Coloplast A/S is a Danish company that has been manufacturing products for people with stoma, incontinence, and wound care needs since 1957. The company's headquarters is located in Humlebæk, Denmark, and it employs over 12,000 employees worldwide. Coloplast A/S ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Coloplast A/S's Equity

Coloplast A/S's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Coloplast A/S's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Coloplast A/S's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Coloplast A/S's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Coloplast A/S’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Coloplast A/S stock

What is the equity of Coloplast A/S this year?

Coloplast A/S has equity of 17.94 B DKK this year.

What was the equity of Coloplast A/S compared to the previous year?

The equity of Coloplast A/S has increased/decreased by 116.38% increased compared to the previous year.

What impact does a high equity have on investors of Coloplast A/S?

A high equity is advantageous for investors of Coloplast A/S as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Coloplast A/S?

A low equity can be a risk for investors of Coloplast A/S, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Coloplast A/S affect the company?

An increase in equity of Coloplast A/S can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Coloplast A/S affect the company?

A reduction in equity of Coloplast A/S can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Coloplast A/S?

Some factors that can affect the equity of Coloplast A/S include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Coloplast A/S so important for investors?

The equity of Coloplast A/S is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Coloplast A/S take to change the equity?

To change equity, Coloplast A/S can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Coloplast A/S pay?

Over the past 12 months, Coloplast A/S paid a dividend of 22.71 DKK . This corresponds to a dividend yield of about 2.86 %. For the coming 12 months, Coloplast A/S is expected to pay a dividend of 24.14 DKK.

What is the dividend yield of Coloplast A/S?

The current dividend yield of Coloplast A/S is 2.86 %.

When does Coloplast A/S pay dividends?

Coloplast A/S pays a quarterly dividend. This is distributed in the months of January, June, January, January.

How secure is the dividend of Coloplast A/S?

Coloplast A/S paid dividends every year for the past 0 years.

What is the dividend of Coloplast A/S?

For the upcoming 12 months, dividends amounting to 24.14 DKK are expected. This corresponds to a dividend yield of 3.04 %.

In which sector is Coloplast A/S located?

Coloplast A/S is assigned to the 'Health' sector.

Wann musste ich die Aktien von Coloplast A/S kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Coloplast A/S from 12/10/2024 amounting to 0.71 DKK, you needed to have the stock in your portfolio before the ex-date on 12/9/2024.

When did Coloplast A/S pay the last dividend?

The last dividend was paid out on 12/10/2024.

What was the dividend of Coloplast A/S in the year 2023?

In the year 2023, Coloplast A/S distributed 21 DKK as dividends.

In which currency does Coloplast A/S pay out the dividend?

The dividends of Coloplast A/S are distributed in DKK.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Coloplast A/S stock can be added to a savings plan with the following providers: Trade Republic and Consorsbank

Andere Kennzahlen von Coloplast A/S

Our stock analysis for Coloplast A/S Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Coloplast A/S Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.